| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/29/2004 | US20040147904 Methods and devices for delivery of agents to breast milk ducts |
| 07/29/2004 | US20040147754 Novel process |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis |
| 07/29/2004 | US20040147725 for cancer treatment by inducing apoptosis; monoclonal antibodies; genetic engineering; kits |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147714 High linear content; low molecular weight, narrow range; using alkali metal secondary amine polymerization aide |
| 07/29/2004 | US20040147614 Serotonin receptor antagonist; administering reboxetine; psychological disorders |
| 07/29/2004 | US20040147613 Synergistic mixture; blocking neurotransmitters; dopamine receptors; haloperidol and (meth)amphetamine |
| 07/29/2004 | US20040147610 Aging resistance; anticancer agents; neurodegradation disease;amyotropic lateral sclerosis; Alzheimer's disease |
| 07/29/2004 | US20040147600 Mixture of drug with insulin; antidiabetic agents |
| 07/29/2004 | US20040147599 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 07/29/2004 | US20040147596 Antidiabetic agents; immunology diseases; antiinflammatory agents |
| 07/29/2004 | US20040147591 Viricides; anticancer agents; immunostimulant |
| 07/29/2004 | US20040147589 Indolone derivatives having vascular damaging activity |
| 07/29/2004 | US20040147586 Antiproliferative agents; anticancer agents; glioblastomas; antidiabetic agents; autoimmune disorders; skin disorders; antiarthritic agents; antiinflammatory agents; cardiovascular disorders |
| 07/29/2004 | US20040147580 Therapy for bacteria infections |
| 07/29/2004 | US20040147577 Heterocyclic compounds |
| 07/29/2004 | US20040147576 Cardiovascular disorders; thrombosis; anticoagulants |
| 07/29/2004 | US20040147573 Metalloproteinase inhibitors |
| 07/29/2004 | US20040147571 Substituted oxazoles and thiazoles as hppar alpha agonists |
| 07/29/2004 | US20040147567 Control appetites; obesity; eating disorders |
| 07/29/2004 | US20040147562 Controlling cell gene expression; moderate cell proliferation; anticancer agents; antiinflammatory agents; cardiovascular disorders; autoimmune disease |
| 07/29/2004 | US20040147556 Analgesics; anxiolytuic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147555 Anticoagulants; brain disorders; blood circulation disorders; myocardial infraction |
| 07/29/2004 | US20040147553 Efficiency; side effect reduction; antiarthriutic agents; autoimmune diseases |
| 07/29/2004 | US20040147546 Heterocyclic compounds |
| 07/29/2004 | US20040147531 Neurodegradation diseases; alzheimer's disease; down's syndrome; antidiabetic agents |
| 07/29/2004 | US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 07/29/2004 | US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147511 Prevent premature labor; dymenorrhea |
| 07/29/2004 | US20040147508 Biologically active methylene blue derivatives |
| 07/29/2004 | US20040147506 Muscarinic acetylcholine receptor antagonist; Parkinson's disease; dystonia; analgesics; irritable bowel syndrome |
| 07/29/2004 | US20040147505 Neurodegradative diseases; antiinflammatory agents; analgesics; drug abuse |
| 07/29/2004 | US20040147500 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 07/29/2004 | US20040147487 Inositol derivatives for increasing chloride secretion and inhibiting inflammation |
| 07/29/2004 | US20040147472 Antisense modulation of transforming growth factor beta receptor II expression |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040147463 For therapy of cancer |
| 07/29/2004 | US20040147456 For therapy and prophylaxis of thrombolytic condition |
| 07/29/2004 | US20040147449 For inhibition of vascularization and for cancer therapy |
| 07/29/2004 | US20040147446 Administration of growth hormone or analogues thereof, preferably human growth hormone, in a low dose for therapy of patients in need of increasing insulin sensitivity |
| 07/29/2004 | US20040147438 For therapy of neuroblastoma |
| 07/29/2004 | US20040147003 Comprises nucleotide sequences coding kinase for use as tool in identifying modulators for treatment and prevention cell proliferative disorders |
| 07/29/2004 | US20040146981 DNA encoding human serine protease D-G |
| 07/29/2004 | US20040146953 Assay |
| 07/29/2004 | US20040146946 used to study oxidative stress-related disorders and diseases and drug screening treatments for Alzheimer's disease |
| 07/29/2004 | US20040146945 used to study oxidative stress-related disorders and diseases and drug screening treatments for Alzheimer's disease |
| 07/29/2004 | US20040146930 for diagnosing susceptibility to a pathological condition based on the presence or absence of mutation; drug screening; genetic engineering |
| 07/29/2004 | US20040146923 for treatment of tendinitis and tendon or ligament defects and in related tissue repair, wound healing, and augmenting bone morphogenetic protein (bmp) activity |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146595 Breast cancer ; therapy containing plant extracts |
| 07/29/2004 | US20040146523 Use of the protein UK114, also known as MSP 14, for the preparation of medicaments for the treatment or the prophylaxis of chronic active hepatitis |
| 07/29/2004 | US20040146513 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 07/29/2004 | US20040146488 Gene expression of protein with ability to chaperon antigenic peptides of tumor cells to antigen-presenting cells (APCs); selective replication in and killilng of tumor cells; immunotherapy; antimetastasis and anticarcinogenic agents |
| 07/29/2004 | DE10301300A1 Verwendung von acylierten 4-Amidino- und 4-Guanidinobenzylaminen zur Inhibierung von Plasmakallikrein Use of acylated 4-amidino and 4-Guanidinobenzylaminen for the inhibition of plasma kallikrein |
| 07/29/2004 | CA2513042A1 Blood-brain barrier disruption inhibitor |
| 07/29/2004 | CA2512765A1 Therapeutic agent for schizophrenia |
| 07/29/2004 | CA2512676A1 Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy |
| 07/29/2004 | CA2512673A1 2-o sulfatase compositions and related methods |
| 07/29/2004 | CA2511858A1 Metastin derivative and use thereof |
| 07/28/2004 | EP1440976A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/28/2004 | EP1440962A1 Stabilized compositions of aqueous reduced coenzyme q solution |
| 07/28/2004 | EP1440709A2 Combinations comprising cGMP PDE5 inhibitors. |
| 07/28/2004 | EP1440688A1 Peroxisome proliferator activated receptor ligands and process for producing the same |
| 07/28/2004 | EP1440687A1 Antiradicals and fat compositions, foods, drinks, drugs or feeds containing the antiradicals |
| 07/28/2004 | EP1440163A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566 |
| 07/28/2004 | EP1440161A2 7118, a human arginine n-methyltransferase family member and uses therefor |
| 07/28/2004 | EP1440159A2 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 07/28/2004 | EP1440085A2 Transient immortalization of cells by oncogenic proteins or telomerase |
| 07/28/2004 | EP1440083A2 Molecules |
| 07/28/2004 | EP1440079A1 Acyclic linker-containing oligonucleotides and uses thereof |
| 07/28/2004 | EP1440073A1 Pde9 inhibitors for treating cardiovascular disorders |
| 07/28/2004 | EP1440072A2 Purine analogs having hsp90-inhibiting activity |
| 07/28/2004 | EP1440071A1 Imidazopyridine compounds as 5-ht 4? receptor modulators |
| 07/28/2004 | EP1440062A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 07/28/2004 | EP1440059A1 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists |
| 07/28/2004 | EP1440057A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/28/2004 | EP1440052A1 Benzamide derivatives as antagonists of orexin receptors |
| 07/28/2004 | EP1439858A1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions |
| 07/28/2004 | EP1439849A2 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 07/28/2004 | EP1439841A2 Androgen receptor modulators and methods of use thereof |
| 07/28/2004 | EP1439840A1 Monobactam antibacterial compounds and methods of use thereof |
| 07/28/2004 | EP1439839A1 A combination comprising combretastatin and anticancer agents |
| 07/28/2004 | EP1439837A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 07/28/2004 | EP1439836A1 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome |
| 07/28/2004 | EP1439834A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/28/2004 | EP1439833A1 Combination of liponic acid and glutamine in food and pharmaceutical products |
| 07/28/2004 | EP1439827A2 Inhalation of vapour of therapeutical substances |
| 07/28/2004 | EP1439820A2 Methods and dosage forms for improving the bioavailability of therapeutic agents |
| 07/28/2004 | EP1401473A4 Transporters comprising spaced arginine moieties |
| 07/28/2004 | EP1311660A4 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4 |
| 07/28/2004 | EP1238095A4 Compositions and methods for caspase-induced apoptosis |
| 07/28/2004 | EP1073430B1 Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders |
| 07/28/2004 | EP1052996B1 Medicine for treating apoptosis dysfunction containing oligosaccharides |
| 07/28/2004 | EP1051383B1 Hydroxylation activated prodrugs |
| 07/28/2004 | EP1047781B1 Il-18 receptors |
| 07/28/2004 | EP1009412B1 Use of inosine for the manufacture of a medicament for stimulating axonal outgrowth of central nervous system neurons |